PROSPECTUS

This document is the electronic version of the original version of the prospectus relating to a Belgian transaction in accordance with Belgian laws and regulations.

The availability of this document on the internet in an electronic format is limited to the websites of Omega Pharma, BNP Paribas Fortis, Dexia and ING, and is exclusively for the Belgian market. Copies of this electronic version on any other website or at any other place are strictly prohibited. Neither Omega Pharma, BNP Paribas Fortis, Dexia, nor ING can be held responsible for non-authorized copies or distributions.

This prospectus, and more specifically this electronic version, is not an offer to acquire or sell securities nor a request to acquire or sell securities (i) in any jurisdiction where such offer or request is prohibited or (ii) to whom it is illegal to make such offer or request.

Neither this prospectus nor any announcement of other information may be distributed publicly in any jurisdiction outside Belgium where a registration-, qualification- or any other obligation is or would be in force in regard to an offer to acquire or sell financial instruments, and in specific (without limitation) these cannot be distributed in the United States, Canada, Australia, the United Kingdom and Japan. Any non-compliance with these restrictions may constitute a violation of the financial legislation or regulation of the United States, Canada, Australia, the United Kingdom and Japan or other jurisdictions. Omega Pharma, BNP Paribas Fortis, Dexia and ING will not be liable for a violation of these restrictions by any person.

By clicking the link below you declare that you have read and will respect the warning above and that (i) you are a person residing in Belgium; (ii) you are not domiciled in the United States; (iii) you are not residing in Australia or Canada; and (iv) you are not residing or domiciled in Japan and you agree not to send information from this website to any person residing or domiciled outside Belgium.